Josep Bassaganya-Riera Named 2017 Innovator of the Year by Roanoke-Blacksburg Technology Council
BLACKSBURG, VA, April 24, 2017—The Roanoke-Blacksburg Technology Council (RBTC) honored a talented group of companies and individuals at its annual TechNite awards banquet, which was held at the Hotel Roanoke & Conference Center on April 21, 2017. TechNite is an annual celebration of the Roanoke - Blacksburg region’s technology community. Josep Bassaganya-Riera was selected as the winner of the 2017 RBTC’s Innovator of the Year award.
Josep Bassaganya-Riera is a serial entrepreneur who founded three biotech Companies, including BioTherapeutics at the Virginia Tech Corporate Research Center, and leads the Nutritional Immunology and Molecular Medicine Laboratory at the Biocomplexity Institute of Virginia Tech. He has demonstrated a track record of successfully leveraging advanced informatics and computational modeling to accelerate the development of innovative technologies into marketable nutritionals such as Pervida® brand products and therapeutics for inflammatory bowel disease (IBD) such as BT-11.
“It is a distinct honor and a privilege to accept the 2017 RBTC Innovator Award. Transformative innovation is only possible with the unwavering resolve, hard work, loyalty and dedication of a fantastic group of individuals. I am proud that our team shares a vision for the future of precision medicine and health.” Said Dr. Bassaganya-Riera, the director of Nutritional Immunology and Molecular Medicine Laboratory and the Founder of BioTherapeutics.
Bassaganya-Riera spoke about his vision for precision medicine during Virginia Tech’s most recent TEDx event. In his discussion, he explained how modeling and simulation of immunological systems helps capture human variation and diversity, and offers clinicians and patients a more rapid pipeline between clinical trials and personalized, individualtreatments for human diseases.
For More Information:
The NIMML Institute is a 501 (c) (3) non-profit public charity foundation focused on a transdisciplinary, team-science approach to precision medicine at the interface of immunology, inflammation, and metabolism. The NIMML Institute team has led numerous large-scale transdisciplinary projects and is dedicated to solving important societal problems by combining the expertise of immunologists, computational biologists, toxicologists, modelers, translational researchers, and molecular biologists. The Institute is headquartered in Blacksburg, VA. For more information, please visit www.nimml.org or contact email@example.com.